Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L31 pseudogene 11 (RPL31P11) is a processed pseudogene that resembles the ribosomal protein L31 gene (RPL31), but does not encode a functional protein. Pseudogenes like RPL31P11 are sometimes formed by reverse transcription and integration of mRNA back into the genome, lacking necessary regulatory elements for expression and function[1][3][6][7]. The actual ribosomal protein L31 gene encodes a component of the 60S ribosomal subunit critical for protein synthesis, but RPL31P11 itself is not expressed and has no known functional role in cellular biology or any documented involvement in disease, drug interaction, or therapeutic targeting[1][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 11 (RPL31P11).